Skip to main content

What does PD-L2 do?

What does PD-L2 do?

PD-L2 plays an important role in immune tolerance and autoimmunity. Both PD-L1 and PD-L2 can inhibit T cell proliferation and inflammatory cytokine production. Blocking PD-L2 has been shown to exacerbate experimental autoimmune encephalomyelitis. Unlike PD-L1, PD-L2 has been shown activate the immune system.

Do macrophages have PD-L1?

The level of PD-L1 in macrophages is significantly associated with the level of PD-L1 in tumor cells and infiltration by CD8+ T cells, suggesting a connection between high PD-L1 and “hot” tumors.

What is PD-L1 and PD-L2?

Programmed death ligand 1 (PD-L1) and PD-L2 are ligands for PD-1; the former is ubiquitously expressed in inflamed tissues, whereas the latter is restricted to antigen-presenting cells. PD-L2 binds to PD-1 with 3-fold stronger affinity compared with PD-L1.

What cells express PD-L2?

PD-L2 appears to be expressed on activated CD4 and CD8T cell subsets. Moreover, as PD-1 molecule, PD-L2 engagement at the surface of T cells is able to down-modulate cytokine production and cell proliferation.

Where is PD-L2 expressed?

Recently, however, PD-L2 has been identified as expressed by a range of solid tumors including non-small cell lung carcinoma, head and neck squamous cell carcinoma, gastric, oesophageal, renal cell carcinoma, and hepatocellular carcinoma (5–9).

Do tumor cells express PD-L2?

Although PD-L2 has been historically considered a minor ligand, it binds to PD-1 with a two- to six-fold higher affinity as compared to PD-L1. PD-L2 can be expressed by immune, stromal, or tumor cells.

Is PD-1 expressed on monocytes?

PD-1 expression was determined on the monocyte subsets (classical, intermediate, non-classical) by flow cytometry. In case of late-onset sepsis (LOS), the same analysis was performed. Our results demonstrated that on the 5th DOL, PD-1 receptors were present in all the monocyte subsets.

Which immune cells express PD-L1?

PD-L1 is widely expressed on antigen-presenting cells and other immune cells (IC)1,2,4 and is upregulated on tumor cells (TC) from a broad range of cancer types, including HNSCC. The PD-1/PD-L1 interaction is a major immune checkpoint that has been implicated in the adaptive immune resistance of HNSCC1,2,3.

How is PD-1 activated?

NFAT1 rapidly activates PD-1 expression following TCR stimulation and this is via NFAT activation and nuclear translocation that PD-1 expression reflected the strength of TCR stimulation integrated by T cells.

Is PD-L1 expressed on T cells?

Abstract. Programmed cell death protein 1 (PD-1) is expressed on T cells upon T cell receptor (TCR) stimulation. PD-1 ligand 1 (PD-L1) is expressed in most tumor environments, and its binding to PD-1 on T cells drives them to apoptosis or into a regulatory phenotype.

How does PD-L1 therapy work?

When PD-1 binds to PD-L1, it basically tells the T cell to leave the other cell alone. Some cancer cells have large amounts of PD-L1, which helps them hide from an immune attack. Monoclonal antibodies that target either PD-1 or PD-L1 can block this binding and boost the immune response against cancer cells.

What is the role of PD-1 in contributing to the control of T cell responses?

PD-1 as an immune checkpoint molecule down-regulates T cell activity during immune responses in order to prevent autoimmune tissue damage. In chronic infections or tumors, lasting antigen-exposure leads to permanent PD-1 expression that can limit immune-mediated clearance of pathogens or degenerated cells.

Can PD-L2 expression be up-regulated in stat6-deficient macrophages?

The up-regulation of PD-L2 expression was completely ablated in the IL-4Rα −/− macrophages, although a very small number of Stat6-deficient macrophages were able to up-regulate PD-L2 expression. However, PD-L2 expression is still severely diminished in these Stat6 −/− macrophages.

How do Th1 and Th2 cells up-regulate PD-L1 on macrophages in the periphery?

Here, we find that Th1 and Th2 cells can differentially up-regulate PD-L1 and PD-L2 on macrophages in the periphery; hence, they are the major determinant of the costimulatory signals that are received by subsequent T cells that interact with macrophages expressing PD-L1 or PD-L2.

Is PD-L1 a marker for macrophages primed for IFN-γ activation?

Whereas PD-L2 might be a marker of alternatively activated macrophages, PD-L1 could be a marker for macrophages “primed” to be sensitive to subsequent IFN-γ signaling. Our results also show that the up-regulation of PD-L1 and PD-L2 expression is mediated by the Jak/Stat pathway.

Does PD-L2 expression affect PFS in lung adenocarcinoma?

Moreover, Shinchi et al. (21) found that patients with high expression of PD-L2 (TPS ≥ 1%) had longer OS and PFS in lung adenocarcinoma. In lung squamous cell carcinoma, Matsubara et al. (22) also pointed out that higher expression of PD-L2 had longer OS than patients with lower expression.